Symphony Clinical Research? Announces VP Appointment
News Feb 21, 2013
Ms. Zarish is responsible for establishing and implementing the operational objectives and clinical processes employed by the global clinical team to deliver exceptional customer service with an unparalleled commitment to quality. She provides leadership to develop, grow and optimize the capabilities of Study Development, Study Management, Study Support and Document Management functions.
Ms. Zarish comes from Abbott Global Pharmaceutical Research & Development where she led an international team of study managers in the execution of clinical trial operations in multiple therapeutic areas. Kate was instrumental in the harmonization of global processes, tools and training programs for clinical study operations management, as well as standardizing study training for the monitoring staff. She maintains her certification as a Clinical Research Associate from ACRP.
“I am proud to be part of an organization that thinks about the patient first,” said Ms. Zarish. “The high standards we have established for in-home clinical services allows for trained health care professionals to ensure patient safety and to provide data with high integrity. It is the complete package for the patient, site and sponsor.”
Commenting on the new appointment, Nicki Norris, CEO states, “Kate’s role is critical in meeting the explosive demand for in-home clinical services. The pharmaceutical industry worldwide is beginning to realize the importance of reaching the intent-to-treat pool, accommodating debilitated patients, and retaining study participants all while completing trials on time. This is exactly what Symphony’s clinical services provide to our clients.”
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE
Microbiotica Enters into Microbiome Collaboration with GenentechNews
Strategic collaboration for microbiome biomarker signatures and therapeutic discovery based on Genentech’s inflammatory bowel disease pipeline.READ MORE